Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients (Q35228266)

7 August 2017

title

Adipogenic changes of hepatocytes in a high-fat diet-induced fatty liver mice model and non-alcoholic fatty liver disease patients (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

7 August 2017

main subject

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

Xiaoli Pan

1 reference

7 August 2017

Pei Wang

1 reference

7 August 2017

Jinzhuo Luo

1 reference

7 August 2017

Zhijun Wang

1 reference

7 August 2017

Yuhu Song

1 reference

7 August 2017

Jin Ye

1 reference

7 August 2017

Xiaohua Hou

1 reference

7 August 2017

language of work or name

1 reference

20 August 2014

1 reference

7 August 2017

1 reference

inferred from page(s)

published in

Endocrine

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

834-847

1 reference

Nonalcoholic fatty liver disease: pathology and pathogenesis

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Adipokines in inflammation and metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Use of a low-speed, iso-density percoll centrifugation method to increase the viability of isolated rat hepatocyte preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

A lipidomic analysis of nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Human fatty liver disease: old questions and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Thiazolidinediones regulate adipose lineage dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Forming functional fat: a growing understanding of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

The role of paracrine and autocrine signaling in the early phase of adipogenic differentiation of adipose-derived stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Regulation of brown adipogenesis by the Tgf-β family: involvement of Srebp1c in Tgf-β- and Activin-induced inhibition of adipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Adiponectin and its receptors in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Non-alcoholic fatty liver disease: a diabetologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

A stress signaling pathway in adipose tissue regulates hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Tissue-resident macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Kupffer cell activation is a causal factor for hepatic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-014-0384-X

Kupffer cell depletion prevents but has no therapeutic effect on metabolic and inflammatory changes induced by a high-fat diet

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25138963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25138963

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12020-014-0384-X

1 reference

7 August 2017

1 reference